14. How should really the corporate design and style and control their paper documentation procedure to forestall the unauthorised re-creation of GMP details?29 along with the EU recommendations within the formalised threat assessment for ascertaining the right good manufacturing practice for excipients of medicinal solutions for human use. An arra